New Delhi : Sanofi Pasteur announced the launch of paediatric 6-in-1 vaccine, Hexaxim, which provides protection against six major childhood diseases in India.
The ready to use fully liquid vaccine provides protection against diphtheria, tetanus, pertussis (whooping cough), polio, haemophilus influenza B and hepatitis B, Sanofi Pasteur said in a statement.
It is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age, it added.
Sanofi Pasteur India, Nepal and Sri Lanka Country Head Jean-Pierre Baylet said, “Hexaxim brings to life Sanofi Pasteur’s mission to improve human health by developing superior innovative vaccination solutions against infectious diseases.”
“Given the large influx of patients met by pediatricians in India, Hexaxim will offer convenience and ensure consistency in administering the right dose of each antigen every single time,” he added.
Hexaxim, during its clinical study assessment, was found to be safe and well tolerated as a primary series and booster vaccination in all schedules, countries, and ethnicities tested, Sanofi Pasteur said.
Each dose of Hexaxim takes 24 to 36 months for manufacturing, of which 70 per cent of the time is spent on quality tests, it added.
Sanofi Pasteur is the vaccines global business unit of pharma major Sanofi.
supriya kashyap
Latest posts by supriya kashyap (see all)
- Natco’s partner Alvogen gets nod for influenza drug in US - November 6, 2017
- USFDA moves to more efficient global pharmaceutical manufacturing inspections - November 6, 2017
- Sanofi refines expectations on drop in sales at diabetes arm - November 6, 2017
